Nicolaou Georghios, Ismail Mohamed, Cheng Davy
Department of Anesthesia and Perioperative Medicine, London Health Sciences Centre, Schulich School of Medicine & Dentistry, Western University, 339 Windermere Road, Room C3-172, London, Ontario, N6A 5A5, Canada.
Anesthesiol Clin. 2013 Jun;31(2):451-78. doi: 10.1016/j.anclin.2013.01.001.
Thoracic endovascular aortic repair (TEVAR) has revolutionized thoracic aortic surgery and has increased the options available to the aortic specialist in treating thoracic aortic disease. TEVAR is less invasive, and is associated with a decrease in perioperative morbidity and mortality when compared with open surgical repair. The dramatic expansion of TEVAR activity has necessitated a better definition for the indications, contraindications, and limitations of this new technology. Ideally TEVAR should be performed in specialized aortic centers providing a full range of diagnostic and treatment options, using a multidisciplinary team approach.
胸主动脉腔内修复术（TEVAR）彻底改变了胸主动脉手术，并增加了主动脉专科医生治疗胸主动脉疾病的可用选择。与开放手术修复相比，TEVAR的侵入性较小，且围手术期发病率和死亡率有所降低。TEVAR应用的急剧增加使得有必要更好地界定这项新技术的适应证、禁忌证和局限性。理想情况下，TEVAR应在提供全方位诊断和治疗选择的专业主动脉中心，采用多学科团队方法进行。
